薈萃國際控股(08041.HK)將從日本購買消毒液銷往香港及中國大陸
格隆匯2月12日丨薈萃國際控股(08041.HK)發佈公告,於2020年2月12日,公司全資附屬公司就建議合作與供應商訂立諒解備忘錄。供應商主要於日本從事貿易業務。
根據諒解備忘錄,供應商將向該集團供應消毒劑及相關產品,包括但不限於透過該集團安排的線上購物平台寄售口罩及洗手液。消毒劑及相關產品將主要採購自日本及韓國,銷往香港及中國大陸的目標客户。
公司稱,公司一直在物色商機,為股東提供更佳的回報。監於當前於香港及中國大陸爆發新型冠狀病毒肺炎,公司擬把握機遇,利用集團於電子商務貿易的經驗透過全球知名線上購物平台向香港及中國大陸客户銷售消毒液及相關產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.